MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
-8.61%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$369M
AUM Growth
+$369M
(-7.6%)
Cap. Flow
+$16.5M
Cap. Flow
% of AUM
4.47%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$16.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $179M | 48.51% | 19,963,157 +1,839,265 | +10% | +$16.5M |
|
2
Aura Biosciences
AURA
$389M
| $66.9M | 18.12% | 3,039,892 | – | – |
|
3
Vaxcyte
PCVX
$4B
| $45.6M | 12.35% | 1,887,478 | – | – |
|
4
Merus
MRUS
$4.98B
| $42.3M | 11.46% | 1,600,000 | – | – |
|
5
Phathom Pharmaceuticals
PHAT
$864M
| $28.1M | 7.62% | 2,067,861 | – | – |
|
|
CMPI
6
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $4.79M | 1.3% | 1,501,716 | – | – |
|
|
OBSV
7
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $2.37M | 0.64% | 1,570,000 | – | – |
|